BTMD vs NAGE
biote Corp. and Niagen Bioscience, Inc., side by side — 5 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BTMD | NAGE |
|---|---|---|
| Revenue | $192.2M | $129.4M |
| Net income | $27.0M | $17.4M |
| Gross margin | 71.5% | 64.3% |
| Net margin | 16.4% | 13.4% |
| Return on equity | · | 28.3% |
| Diluted EPS | $0.74 | $0.20 |
| Dividend / share | · | · |
| Payout ratio | 6.4% | · |
| Free cash flow | $30.2M | · |
| Equity | $-58.5M | $76.5M |
| Net debt / equity | · | · |
| Current ratio | 1.22× | 4.86× |
| Revenue CAGR 5y | · | 16.9% |
| Profit CAGR 5y | · | · |
BTMD bills 1.5× the revenue of NAGE, and keeps more of each dollar of revenue as profit (16.4% against 13.4%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
5 years side by side
| Fiscal year | BTMD | NAGE |
|---|---|---|
| FY2025 | $192.2M | $129.4M |
| FY2024 | $197.2M | $99.6M |
| FY2023 | $185.4M | $83.6M |
| FY2022 | $165.0M | $72.0M |
| FY2021 | $139.4M | $67.4M |
Bottom line
| Fiscal year | BTMD | NAGE |
|---|---|---|
| FY2025 | $27.0M | $17.4M |
| FY2024 | $3.2M | $8.6M |
| FY2023 | $3.3M | $-4.9M |
| FY2022 | $-969,000 | $-16.5M |
| FY2021 | $32.6M | $-27.1M |
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$62,796,000 | BTMD |
| FY2024 | +$97,594,000 | BTMD |
| FY2023 | +$101,790,000 | BTMD |
| FY2022 | +$92,907,000 | BTMD |
| FY2021 | +$71,947,000 | BTMD |
BTMD has reported the higher revenue in every one of these 5 fiscal years. The gap has narrowed since the earliest year compared.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +3.0 pp | BTMD |
| FY2024 | −8.6 pp | NAGE |
| FY2023 | +4.4 pp | BTMD |
| FY2022 | +23.8 pp | BTMD |
| FY2021 | +63.6 pp | BTMD |
The higher net margin has changed hands between BTMD and NAGE over this period.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NAGE's net margin has been more volatile than BTMD's over the 5 comparable fiscal years — 20.0 percentage points of standard deviation against 10.1.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BTMD and NAGE over these 5 fiscal years — BTMD led in 4 and NAGE in 1.
5 of 16 comparable fiscal years — a year missing data on either side is not counted.